Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00463099
Other study ID # 990426
Secondary ID R01AR053684
Status Completed
Phase
First received
Last updated
Start date January 2002
Est. completion date December 2021

Study information

Verified date February 2024
Source Vanderbilt University Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to determine the effect of modifiable risk factors on knee function, osteoarthritis, and re-rupture of the anterior cruciate ligament (ACL) following ACL reconstruction.


Description:

Disruption of the anterior cruciate ligament (ACL) is among the most frequent musculoskeletal injuries affecting physically active men and women. An estimated 200,000 ACL reconstructions (ACLR) are performed annually, and the incidence of this injury is roughly 1 in 3000 per year. ACL injury has both immediate and long-term implications for an injured person's quality of life, their risk for osteoarthritis (OA), and long-term disability. Currently, ACLR is recommended as the standard of care following an ACL tear based on evidence for improved instrumented laxity, the desire to return to sports play, and evidence for a reduction in future knee injuries. In this research we propose to identify risk factors measurable at the time of injury/surgery in order to estimate the magnitude of the effect of these factors on important quality of life and clinical outcomes (e.g.,OA and incidence of additional surgery) 2 to 10 years after a patient's ACL reconstruction. AIM 1. To identify risk factors for reduced quality of life 2-10 yrs post-ACLR, from information available at the time of surgery; including the characteristics of the patients (age, gender, body mass index, activity level, clinical knee alignment) and their injuries (concurrent meniscus, articular cartilage, and collateral ligament injuries), and treatment decisions made during the initial surgery (e.g., graft choice, meniscus and articular cartilage treatments). AIM 2. To identify risk factors for symptoms and signs of osteoarthritis 2-10 years post-ACLR, from information available at the time of surgery; including the characteristics of the patients (as above) and their injuries (as above), and treatment decisions made during ACLR (as above). AIM 3. To identify risk factors for recurrent ligament disruption and additional arthroscopic knee surgeries of the ACLR knee, from among the characteristics of the patients (as above), their initial injuries (as above), and treatment decisions made during ACLR (as above). The overarching goal of this study is to establish evidence-based medicine practices of counseling patients on prognosis, guiding surgeons on treatment of meniscus and articular cartilage injuries, and post-surgical care, as well as the appropriate evidence for future interventional trials in the targeted subset of ACLRs with poorer outcomes.


Recruitment information / eligibility

Status Completed
Enrollment 3294
Est. completion date December 2021
Est. primary completion date May 2021
Accepts healthy volunteers No
Gender All
Age group 10 Years to 33 Years
Eligibility Inclusion Criteria: - All ACL-deficient candidates scheduled for a unilateral ACL reconstruction at one of the participating MOON sites. - Between 10 and 33 years of age - Injured while playing a sport - Normal contralateral leg (no previous surgeries) Exclusion Criteria: - Persons undergoing a simultaneous bilateral ACL reconstruction - Patients less than 10 years old and older than 33 years old - patients not injured while playing a sport (e.g., MVA, ADL) - Patients unwilling or unable to complete their repeat questionnaire 2, 6, and 10 years after their initial visit.

Study Design


Related Conditions & MeSH terms

  • Rupture
  • Rupture of Anterior Cruciate Ligament

Locations

Country Name City State
United States University of Colorado Boulder Colorado
United States Cleveland Clinic Cleveland Ohio
United States The Ohio State University Columbus Ohio
United States Duke University Durham North Carolina
United States University of Iowa Iowa City Iowa
United States Vanderbilt University Medical Center Nashville Tennessee
United States Hospital for Special Surgery New York New York
United States Washington University at St. Louis Saint Louis Missouri

Sponsors (3)

Lead Sponsor Collaborator
Vanderbilt University Medical Center National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other ACL graft failure 2, 6, and 10 years
Primary patient-reported outcome measures Sports function (as measured by the KOOS and IKDC). Activity level (as measured by the Marx activity rating scale). General health (as measured by the SF-36). 2, 6, and 10 years
Secondary Signs and symptoms of osteoarthritis Signs of OA (as measured by joint space narrowing on a standing radiograph). Symptoms of OA (as measured by WOMAC and KOOS pain subscales). 2, 6, and 10 years
See also
  Status Clinical Trial Phase
Completed NCT02524652 - Local Infiltration Analgesia vs Adductor Canal Block for Analgesia After Anterior Cruciate Ligament Reconstruction Phase 4
Recruiting NCT02511158 - French Prospective Anterior Cruciate Ligament Reconstruction Cohort Study (FAST)
Recruiting NCT02074917 - Comparison of Dynamic Knee Stability and Functional Outcomes in Anatomical ACL Reconstruction at AM or Central Position N/A
Completed NCT02584452 - Trial Evaluating Postop Pain and Muscle Strength Among Regional Anesthesia Techniques for Ambulatory ACL Reconstruction N/A
Completed NCT01300182 - The Effect of Early WBVT on Neuromuscular Control After ACLR N/A
Recruiting NCT00971451 - Quadriceps Function Prior to Anterior Cruciate Ligament Reconstruction N/A
Completed NCT02420353 - Evaluation of rGH Therapy to Prevent Muscle Atrophy in Patients With ACL Tears Phase 2
Completed NCT02754674 - Comparison of Femoral Tunnel and Clinical Outcome Using Two Anterior Cruciate Ligament Reconstruction Techniques N/A
Completed NCT02173483 - Anterior Cruciate Ligament-reconstruction: Quadriceps Tendon or Hamstrings Tendon? A Prospective Trial N/A
Completed NCT01440348 - Simultaneous Multiple Cruciate Ligament Reconstructions Using a Single Achilles Allograft Phase 4
Completed NCT01391650 - Stability of the Knee Joint After Single and Double Bundle Anterior Cruciate Ligament Reconstruction N/A
Not yet recruiting NCT02833454 - Study of the Anatomical Direct Insertion Anterior Cruciate Ligament Reconstruction N/A
Not yet recruiting NCT02834962 - Study of Single And Double Bundle Anterior Cruciate Ligament (ACL) Graft Cross-sectional Dimensions N/A
Completed NCT02300012 - A Pilot Study to Investigate Biomarkers in Anterior Cruciate Ligament (ACL) Patients and Healthy Controls N/A
Completed NCT02939677 - Can Targeted Exercise Improve Knee Strength Following ACLR (RATE) N/A
Completed NCT02817399 - The Effect of Functional Electrical Stimulation N/A
Recruiting NCT02771548 - Biomechanical Analysis of Dynamic Tasks and Muscular Strength Following Anterior Cruciate Ligament Reconstruction
Completed NCT01361789 - COX-2 Inhibitor Versus Glucocorticoid Versus Both Combined Phase 4
Active, not recruiting NCT02680821 - Reconstruction of the Anterolateral Ligament (ALL) With Revision Anterior Cruciate Ligament (ACL) Surgery N/A
Active, not recruiting NCT00625885 - Multicenter ACL Revision Study (MARS)